Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Locally Advanced and Metastatic Solid Tumors × Taxes × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 8 Recurrent Malignant Solid Neoplasm 1 Locally Advanced or Metastatic Solid Tumors 1 Locally Advanced and Metastatic Solid Tumors 1 Cervical Adenocarcinoma 1 Advanced Solid Tumor 1

Interventions

tislelizumab 1 Taxes 1 Pemetrexed 1 Paclitaxel 1 Oxaliplatin 1 Fluorouracil 1 Etoposide 1 Cisplatin 1 Carboplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04047862 2025-08-22

Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors

BeiGene

Phase 1 Completed

446 enrolled 49 charts

Other solid neoplasm

Locally Advanced and Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡